Who
Ted Yednock
EVP & Chief Innovation Officer
Company insider
Files Form 4 as: EVP & Chief Innovation Officer, Annexon.
In numbers
- Trades disclosed
- 55
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $1.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Feb 2021
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $57K30,646 at $1.85 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,646 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —30,646 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $57K30,646 at $1.85 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $30K5,566 at $5.42 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $30K5,566 at $5.42 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $40K7,857 at $5.11 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $40K7,857 at $5.11 | filing |
| 14 Jul 2025filed 16 Jul 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $2,8791,116 at $2.58 | filing |
| 27 Feb 2025filed 3 Mar 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —272,575 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $24K8,345 at $2.91 | filing |
| 13 Feb 2025filed 18 Feb 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $5,3311,783 at $2.99 | filing |
| 15 Oct 2024filed 17 Oct 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,408 at $0.00 | filing |
| 15 Oct 2024filed 17 Oct 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $10K5,408 at $1.85 | filing |
| 15 Oct 2024filed 17 Oct 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $40K5,408 at $7.41 | filing |
| 19 Sep 2024filed 20 Sep 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K4,500 at $7.10 | filing |
News
No headline names them, or the companies they trade most, lately.